Skip to main content
. 2020 Sep 25;10:15820. doi: 10.1038/s41598-020-72810-0

Figure 2.

Figure 2

Survival curves of patients with intrahepatic cholangiocarcinoma according to the mutation status of IDH1/2. Cancer-specific survival (A) and recurrence-free survival (B).